Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Laking

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Acta Biomaterialia|June 5, 2026
A cancer stem cell-directed nano-chemotherapy enhances anti-PD-L1 immunotherapy in breast cancer by inducing immunogenic cell deathJingjing Wang, Kamel S Ahmed, Dengxuan Mao, et al.
Targeted Oncology|July 13, 2017
EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New ZealandMark McKeage, Mark Elwood, Sandar Tin Tin, et al.
The New Zealand Medical Journal|February 23, 2018
New Zealand's revised Ethnicity Data Protocols must not become a shelved document: a challenge from Hei Āhuru MōwaiJason K Gurney, Nina Scott, Gary Thompson, et al.
International Journal of Pharmaceutics|May 29, 2026
A pH-sensitive nanococktail enabled cancer stem cell elimination, deep tumour penetration, and tumour shrinkageKamel S Ahmed, Emma Nolan, Jingjing Wang, et al.
The New Zealand Medical Journal|February 13, 2025
Establishing a New Zealand brain tumour registry: understanding clinical registry formation in New ZealandHolly Wilson, Caroline Woon, Chris Tse, et al.
JMIR Research Protocols|July 2, 2024
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation SubstudyPhyu Sin Aye, Joanne Barnes, George Laking, et al.
JMIR Cancer|March 3, 2025
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort StudyPhyu Sin Aye, Joanne Barnes, George Laking, et al.
American Journal of Lifestyle Medicine|February 2, 2026
The Potential of Plant-Based Lifestyle Interventions to Reduce the Burden of Disease in a Multi-Crisis EraKomathi Kolandai, Nicholas Wright, Luke Wilson, et al.
The New Zealand Medical Journal|October 28, 2009
Why New Zealand must rapidly halve its greenhouse gas emissionsScott Metcalfe, Alistair Woodward, Alexandra Macmillan, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Acta Biomaterialia|June 5, 2026
A cancer stem cell-directed nano-chemotherapy enhances anti-PD-L1 immunotherapy in breast cancer by inducing immunogenic cell deathJingjing Wang, Kamel S Ahmed, Dengxuan Mao, et al.
Targeted Oncology|July 13, 2017
EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New ZealandMark McKeage, Mark Elwood, Sandar Tin Tin, et al.
The New Zealand Medical Journal|February 23, 2018
New Zealand's revised Ethnicity Data Protocols must not become a shelved document: a challenge from Hei Āhuru MōwaiJason K Gurney, Nina Scott, Gary Thompson, et al.
International Journal of Pharmaceutics|May 29, 2026
A pH-sensitive nanococktail enabled cancer stem cell elimination, deep tumour penetration, and tumour shrinkageKamel S Ahmed, Emma Nolan, Jingjing Wang, et al.
The New Zealand Medical Journal|February 13, 2025
Establishing a New Zealand brain tumour registry: understanding clinical registry formation in New ZealandHolly Wilson, Caroline Woon, Chris Tse, et al.
JMIR Research Protocols|July 2, 2024
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation SubstudyPhyu Sin Aye, Joanne Barnes, George Laking, et al.
JMIR Cancer|March 3, 2025
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort StudyPhyu Sin Aye, Joanne Barnes, George Laking, et al.
American Journal of Lifestyle Medicine|February 2, 2026
The Potential of Plant-Based Lifestyle Interventions to Reduce the Burden of Disease in a Multi-Crisis EraKomathi Kolandai, Nicholas Wright, Luke Wilson, et al.
The New Zealand Medical Journal|October 28, 2009
Why New Zealand must rapidly halve its greenhouse gas emissionsScott Metcalfe, Alistair Woodward, Alexandra Macmillan, et al.
Pageof 5